Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib-resistant BRAF V600E mutation bearing metastatic melanoma cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib-resistant BRAF
V600E
mutation bearing metastatic melanoma cells
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-06-18
DOI
10.1002/mc.23068
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Resistance to MAPK inhibitors in melanoma involves activation of the IGF-1R-MEK5-Erk5 pathway
- (2019) Lucía Benito-Jardón et al. CANCER RESEARCH
- Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines
- (2018) Jingjing Xiao et al. BMC CANCER
- Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten -Null Cells
- (2018) Adam Naguib et al. Cell Reports
- Photoprotective Properties of Isothiocyanate and Nitrile Glucosinolate Derivatives From Meadowfoam (Limnanthes alba) Against UVB Irradiation in Human Skin Equivalent
- (2018) Evan L. Carpenter et al. Frontiers in Pharmacology
- Rotenone induces nephrotoxicity in rats: oxidative damage and apoptosis
- (2017) Xiao-Wen Jiang et al. TOXICOLOGY MECHANISMS AND METHODS
- Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells
- (2017) Marianna Vitiello et al. Oncotarget
- Rotenone induces nephrotoxicity in rats: oxidative damage and apoptosis
- (2017) Xiao-Wen Jiang et al. TOXICOLOGY MECHANISMS AND METHODS
- Mitochondrial oxidative phosphorylation controls cancer cell’s life and death decisions upon exposure to MAPK inhibitors
- (2016) Paola Corazao-Rozas et al. Oncotarget
- Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model
- (2016) Nerea Rebolleda et al. PLoS One
- Antitumor effects of deguelin on H460 human lung cancer cellsin vitroandin vivo: Roles of apoptotic cell death and H460 tumor xenografts model
- (2015) Yu-Chieh Hsu et al. ENVIRONMENTAL TOXICOLOGY
- An update on the rotenone models of Parkinson's disease: Their ability to reproduce the features of clinical disease and model gene–environment interactions
- (2015) Michaela E. Johnson et al. NEUROTOXICOLOGY
- Novel Pactamycin Analogs Induce p53 Dependent Cell-Cycle Arrest at S-Phase in Human Head and Neck Squamous Cell Carcinoma (HNSCC) Cells
- (2015) Gunjan Guha et al. PLoS One
- Molecular Pathways: BRAF Induces Bioenergetic Adaptation by Attenuating Oxidative Phosphorylation
- (2014) R. Haq et al. CLINICAL CANCER RESEARCH
- Oncogenic BRAF Regulates Oxidative Metabolism via PGC1α and MITF
- (2013) Rizwan Haq et al. CANCER CELL
- Deguelin Induces Both Apoptosis and Autophagy in Cultured Head and Neck Squamous Cell Carcinoma Cells
- (2013) Yan-li Yang et al. PLoS One
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- Melanoma: from mutations to medicine
- (2012) H. Tsao et al. GENES & DEVELOPMENT
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Structure based discovery of small molecule suppressors targeting bacterial lysozyme inhibitors
- (2011) Arnout Voet et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring V600EBRAF
- (2011) F Xing et al. ONCOGENE
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- mTORC1-Mediated Cell Proliferation, But Not Cell Growth, Controlled by the 4E-BPs
- (2010) R. J. O. Dowling et al. SCIENCE
- BrafV600E cooperates with Pten loss to induce metastatic melanoma
- (2009) David Dankort et al. NATURE GENETICS
- Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translation
- (2008) A. Y. Choo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started